Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 11,752 shares at $9.47 ($111K) on 2019-06-27, disclosed to the SEC on 2019-07-01.
Open-market sale of $111k BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.47 | 5,876 | $56K | 50.0% |
| 2 | $9.47 | 5,876 | $56K | 50.0% |
| Total | $9.47 avg | 11,752 | $111K | 100% |
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2021-01-19 | $9.6M | — | Filing → |
| BGNE | SELL | 2020-12-16 | $39.2M | — | Filing → |